Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid

The Lancet

Volumn 342, Issue 8864, 1993, Pages 147-148

  Grant, W E ^a   MacRobert, Aj ^a   Bown, S G ^a   Hopper, C ^a   Speight, P M ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLAEVULINIC ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; FLUORESCENCE; HISTOLOGY; HUMAN; IRRADIATION; MOUTH CANCER; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADMINISTRATION, ORAL; AMINOLEVULINIC ACID; CARCINOMA, SQUAMOUS CELL; FLUORESCENCE; HUMANS; LASERS; MOUTH NEOPLASMS; NECROSIS; PALLIATIVE CARE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS;

EID: 0027223605     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(93)91347-O     Document Type: Article

References (10)

1. A study of the effects of photodynamic therapy on the normal tissues of the rabbit jaw
2. Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation
3. Cutaneous phototoxic occurrences in patients receiving Photofrin
4. Porphyrin and haem biosynthesis and its control
5. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolaevulinic acid correlates with localised protoporphyrin IX fluorescence
6. Destruction of erytholeukaemic cells by photoactivation of endogenous porphyrins
7. Endogenous protoporphyrin IX, a clinically useful photosensitiser for photodynamic therapy
8. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model
9. Photodynamic therapy of the normal rat stomach: a comparative study between di-sulphonated aluminium phthalocyanine and 5-aminolaevulinic acid
10. Oral versus intravenous adminstration of 5-aminolaevulinic acid for photodynamic therapy